TAVEGYL sol inj 2 mg/2ml i.m./i.v. 5 amp 2 ml
7680355010294
CH-35501
R06AA04
07.13.1.
1 / 3
google
Details
- Product number
- 3550101
- CPT
- -
- Packaging group
- 5
- Unit
- Ampulle(n)
- Composition
- clemastinum 2 mg ut clemastini fumaras 2.68 mg, sorbitolum 90 mg, ethanolum 96 per centum 140 mg, propylenglycolum 600 mg, natrii citras dihydricus corresp. natrium 0.56 mg, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Tavegyl, Injektionslösung
Injektionslösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.68 MG | Substance | WIZUS |
|
(N/A)
|
90.0 MG | Substance | HBESI |
|
(N/A)
|
140.0 MG | Substance | HBESI |
|
(N/A)
|
600.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.56 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 17.30
Specialties list
Yes
Generic
No
SL addition date:
15/03/1968
Authorization holder
Gebro Pharma AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 35501
- Drug name
- Tavegyl, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- R06AA04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/06/1970
- Authorization expiration date
- 31/12/9999
- IT number
- 07.13.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TAVEGYL sol inj 2 mg/2ml i.m./i.v. 5 amp 2 ml
- Description (DE)
- TAVEGYL Inj Lös 2 mg/2ml i.m./i.v. 5 Amp 2 ml
- Market launch
- 03/06/1970
- Narcotic (BTM)
- No